Progyny Stock Price To Sales
| PGNY Stock | USD 21.86 0.18 0.83% |
Progyny fundamentals help investors to digest information that contributes to Progyny's financial success or failures. It also enables traders to predict the movement of Progyny Stock. The fundamental analysis module provides a way to measure Progyny's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Progyny stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 1.35 | 1.28 |
Progyny | Price To Sales |
Progyny Company Price To Sales Analysis
Progyny's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Progyny Price To Sales | 1.60 X |
Most of Progyny's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Progyny is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Progyny Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Progyny is extremely important. It helps to project a fair market value of Progyny Stock properly, considering its historical fundamentals such as Price To Sales. Since Progyny's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Progyny's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Progyny's interrelated accounts and indicators.
Click cells to compare fundamentals
Progyny Price To Sales Historical Pattern
Today, most investors in Progyny Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Progyny's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Progyny price to sales as a starting point in their analysis.
Progyny Price To Sales |
| Timeline |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Progyny Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Progyny has a Price To Sales of 1.5996 times. This is 92.53% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 85.99% higher than that of the company.
Progyny Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Progyny's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Progyny could also be used in its relative valuation, which is a method of valuing Progyny by comparing valuation metrics of similar companies.Progyny is currently under evaluation in price to sales category among its peers.
Progyny Current Valuation Drivers
We derive many important indicators used in calculating different scores of Progyny from analyzing Progyny's financial statements. These drivers represent accounts that assess Progyny's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Progyny's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 3.6B | 4.5B | 2.9B | 3.5B | 1.6B | 2.1B | |
| Enterprise Value | 3.6B | 4.4B | 2.8B | 3.5B | 1.4B | 2.0B |
Progyny ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Progyny's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Progyny's managers, analysts, and investors.Environmental | Governance | Social |
Progyny Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0618 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 1.66 B | ||||
| Shares Outstanding | 85.41 M | ||||
| Shares Owned By Insiders | 7.50 % | ||||
| Shares Owned By Institutions | 92.50 % | ||||
| Number Of Shares Shorted | 11.65 M | ||||
| Price To Earning | 37.91 X | ||||
| Price To Book | 4.42 X | ||||
| Price To Sales | 1.60 X | ||||
| Revenue | 1.17 B | ||||
| Gross Profit | 253.36 M | ||||
| EBITDA | 67.45 M | ||||
| Net Income | 54.34 M | ||||
| Cash And Equivalents | 122.39 M | ||||
| Cash Per Share | 1.33 X | ||||
| Total Debt | 19.27 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 2.46 X | ||||
| Book Value Per Share | 4.98 X | ||||
| Cash Flow From Operations | 179.1 M | ||||
| Short Ratio | 6.58 X | ||||
| Earnings Per Share | 0.57 X | ||||
| Price To Earnings To Growth | 8.52 X | ||||
| Target Price | 26.57 | ||||
| Number Of Employees | 675 | ||||
| Beta | 1.42 | ||||
| Market Capitalization | 1.87 B | ||||
| Total Asset | 607.1 M | ||||
| Retained Earnings | 144.31 M | ||||
| Working Capital | 304.09 M | ||||
| Net Asset | 607.1 M |
About Progyny Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Progyny's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Progyny using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Progyny based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Progyny Stock Analysis
When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.